Abstract Conventional estrogen receptor a knockout (neo-ERaKO, neo-ERa -/-) mice contain a truncated and chimeric ERa fusion protein that retains 35% estrogendependent transactivation activity, and therefore the in vivo ERa function is difficult to study thoroughly. Furthermore, these neo-ERa -/-mice cannot be used for tissue and temporal specific ERa deletion. Therefore, there is a clear need to establish a floxed ERa mouse line that can knockout ERa specifically and completely in each selected cell type. Here we generated floxed ERa mice using a selfexcising ACN (tACE-Cre/Neo) cassette. Mating the floxed ERa mice with ACTB-Cre mice produces a deletion of the floxed allele disrupting the reading frame of the ERa transcript so that no ERa protein is detected in the ACTBCre/ERa -/-mice. Expression of ERa target genes, such as G-6-PD and lactoferrin, is diminished by over 90% in the ACTB-Cre/ERa -/-uterus, but not in the neo-ERa -/-uterus. Furthermore, we also validated that ACTB-Cre/ ERa -/-females have a hypoplastic internal genital tract, polycystic ovaries with hemorrhagic follicles, infertility, and higher body weight. Together, our data clearly demonstrate that the newly established floxed ERa mouse is a reliable mouse model for future studies of ERa roles in vivo in the selective estrogen target tissues. The complete knockout of ERa in the ACTB-Cre/ERa -/-mice will also provide an improved mouse model to study the role of ERa in vivo.
Introduction
Estrogens regulate the growth, differentiation, and developmental functions in a broad range of target tissues, such as the reproductive system, bone, and cardiovascular systems [1] . Estrogens actions are mediated by the cell-and tissue-specific transcriptional regulation of estrogen receptors (ERs) target genes via ERs [2] . ERs are members of the nuclear receptor (NR) superfamily and act as ligandinducible transcription factors [3, 4] , which are encoded by two distinct genes, ERa and ERb. Classically, upon ligand binding, the ERs undergo a conformational change, receptor dimerization, and recruitment of distinct co-regulator complexes for transcriptional control [5] . Although in vitro assays have demonstrated that ERa and ERb have similar DNA and ligand binding properties [6, 7] , ERa and ERb display a variety of differences in terms of tissue distribution, transcriptional activation, and knockout (KO) phenotypes [1, 6, 8, 9] . Those studies suggest that ERa and ERb might regulate different target genes' expression and biological functions [2, 6, 10] .
To assay the in vivo ERa functions, Lubahn et al. [11] generated the ERaKO mice (designated as neo-ERa -/-) via the conventional gene KO strategy by insertion of a Neo cassette into exon II of the mouse ERa gene. NeoERa -/-mice do not express the full-length ERa, but contain a truncated and chimeric E1 protein, which results from a novel ERa transcript through alternative splicing, has seven amino acids in the N-terminal A/B regions replaced by the neomycin insert, and retains an intact DNA-binding domain (DBD) and ligand-binding domain (LBD). The E1 protein lacks AF-1 transactivation function, but still possesses estrogen-dependent transactivation capability; thus the conventional neo-ERa -/-mice do not represent a complete null ERa mutant [12] .
In order to characterize the tissue and temporal-specific ERa function in specific target organs, we have generated the floxed ERa mouse line. By mating floxed ERa mice with ACTB-Cre mice, which ubiquitously express Cre recombinase, we generated ERaKO mice (ACTB-Cre/ ERa -/-) to validate KO efficiency and ERa function. Both Dupont et al. [8] and Feng et al. [13] have generated floxed ERa mice to target exon III of the mouse ERa gene. However, it has been reported that variations in the design of the floxed allele in different mouse lines might generate unique or distinct phenotypes. For example, it is expected that the floxed androgen receptor (AR) mouse line should present wild type (Wt) phenotypes with normal hormonal profile and fertility [14] ; yet, there is an example of a floxed AR mouse line that has an altered hormonal profile and reduced fertility [15] . Therefore, it is necessary to establish and characterize each independent ''floxed'' ERa mouse line. The floxed ERa mice developed in our laboratory differ somewhat in the strategy used to ''flox'' exon III (see Table 1 ). Importantly, however, we are the first group to characterize whether any residual ERa protein is expressed in ERa -/-mice (Table 1) . Using different antibodies recognizing either the N terminus or C terminus of ERa, we demonstrate in this study the generation of a complete null ERa mouse without any remaining ERa protein. We have performed comparisons in expression of ERa, and of ERa transactivation capabilities, between the neo-ERa -/-and the ACTB-Cre/ERa -/-mice.
Materials and methods

Injection of targeted embryonic stem (ES) cells into mouse blastocysts and germline transmission of floxed ERa
The cloned mouse ERa fragment was obtained from a 129Sv/J BAC clone of the ERa locus from the Microarray and Genomics Facility at Roswell Park Cancer Institute (Buffalo, NY) and used to generate a targeting construct where exon III of the mouse ERa gene was flanked by loxP sites [16] . First, an oligonucleotide containing a 34 bp loxP site was inserted into an NheI site 5 0 to exon III. Next, a self-excising ACN (tACE-Cre/Neo) cassette was inserted into an Eco47III site 3 0 to the same exon [17] . The selfexcising ACN cassette includes a testis-specific promoter tACE (angiotensin-converting enzyme) driving the expression of Cre recombinase. The tACE-Cre fragment is adjacent to a Neo marker gene, and the entire tACE-Cre/ Neo cassette is flanked by two loxP sites. The targeting vector was linearized and electroporated into 129 Sv/J mouse ES cells. ES cells containing the targeted ERa allele were identified by Southern Blot using an EcoRV digestion of ES cell genomic DNA. The probe consisted of a PstI/ BglII fragment obtained from intron II.
The ES cells heterozygous for the allele containing the integrated homologous recombinant were injected into Wt mouse blastocysts. Chimeric males were mated to Wt C57BL/6 females. Two types of deletions were observed to occur in the testes of chimeric males: a Type I deletion where both the ACN cassette and exon III fragments are deleted and a Type II deletion where the ACN cassette, but not exon III, is deleted. In the Type II deletion, the mutant allele is marked by two loxP sites flanking exon III of the ERa gene and does not contain the ACN cassette.
Southern blot analysis of tail genomic DNA obtained from the Fl progeny was performed to identify Fl mice heterozygous for the Type II deletion (ERa fl/? ). These mice were bred to homozygosity to generate homozygote floxed ERa mice (ERa fl/fl ) and backcrossed with the pure C57BL/ Generation and genotyping of ACTB-Cre/ERa -/-mice In order to generate the ACTB-Cre/ERa -/-mice, the ERa fl/fl female mice were crossed with ACTB-Cre transgenic male mice (Jackson Laboratories, Bar Harbor, ME). These mice ubiquitously express Cre recombinase under the control of the b-actin promoter. After two generations of mating, ACTB-Cre/ERa -/-mice were developed. Genomic DNA was isolated from tail biopsies and used as a template for PCR genotyping as previously described [14] . The primer pairs used were as follows: P1:
0 (see Fig. 1a ; floxed ER allele).
The sizes of the P1-P2 fragments from Wt ERa, floxed ERa, and ERa KO allele were 741, 881, and 223 bp, respectively. The size of the Cre fragment was 411 bp. The PCR for the genotyping was performed with the P1, P2, and Cre primer mixture.
Fertility test
Five 14-to 16-week-old Wt, ACTB-Cre/ERa ?/-, and ACTB-Cre/ERa -/-females were mated with known fertile males for 18 weeks. The number of pups and litters was recorded.
RNA isolation, semi-quantitative RT-PCR, and real-time PCR Total RNA was extracted and purified from the uteri of different female genotypes at 12 weeks of age using Trizol (Invitrogen, Carlsbad, CA), according to the manufacturer's instructions, then 3 lg RNA was subjected to reverse transcription using Superscript III (Invitrogen, Carlsbad, CA). The resulting first strand cDNA was subjected to semi-quantitative RT-PCR with the following ERa-specific primer pairs: P3, 5
0 -GGTGCCCTACTA CCTGGAG-3 0 and P4, 5 0 -GCCCACTTCGT AACACT TGCG C-3 0 . P3 and P4 are located in the mouse ERa exon II and exon IV respectively. The sizes of P3-P4 fragments from Wt and ERaKO transcripts were 367 and 177 bp, respectively. The real-time PCR was performed with first 0 -CGTCTGCCCTATCAACTTTCG-3 0 . Each sample was run in triplicate, and data were analyzed using iCycler iQ software (Biorad, Hercules, CA).
Antibodies
Mouse monoclonal anti-GAPDH antibody 6C5, rabbit polyclonal antibody H-184 directed against the 2-185 amino acids (a.a.) of human ERa N terminus, and MC-20 against the last 20 a.a. of the mouse ERa C terminus were obtained from Santa Cruz Biotechnology.
ERaKO N terminus cDNA construct
The putative N-terminal ERaKO cDNAs were generated by PCR from the pcDNA3-flag-mERa plasmid using the forward primer: 5 0 -CGGGATCCATGACCATGACCCTT CACACCAAAG-3 0 and reverse primer: 5 0 -CGGAATTC TCATTGTGTCCTGTAGAAGGCGGGAG-3 0 and subsequently constructed into pcDNA3-flag vector. The correct construction of the plasmid was verified by sequencing and protein expression was confirmed by TNT in vitro expression.
Western blotting
Protein extracts were prepared from the uteri of different mouse genotypes as described previously [18, 19] , 80 lg of protein was separated on a 10% gel by SDS-PAGE, and transferred onto a nitrocellulose membrane. ERa protein was detected with the rabbit polyclonal antibodies H-184 and MC-20 (Santa Cruz, CA). The same blot was hybridized with an anti-GAPDH antibody to control for equal loading (Santa Cruz, CA).
Immunohistochemistry (IHC)
The IHC was carried out as described previously [19, 20] . In brief, the paraffin-embedded tissue blocks were cut at 4-lm thickness, dewaxed, and rehydrated. Antigens were retrieved by boiling in 10 mM citrate buffer (pH 7.0) for 10 min. The sections were incubated in 0.5% H 2 O 2 in PBS for 30 min at room temperature to quench endogenous peroxidase. To block nonspecific binding, sections were incubated in 5% normal serum prepared from the host of secondary antibodies for 1 h at 4°C. Sections were incubated with ERa antibodies (MC-20, 1:400) in 3% BSA in PBS overnight at 4°C, and then incubated with 1:200 diluted biotinylated secondary antibody (Vector Laboratories) and ABC solution (Vector Laboratories). The tissues were then stained by AEC followed by Mayer's hematoxylin counterstaining (DAKO, Carpenteria, CA). Negative controls were incubated without primary antibody. [1] . The deletion of exon III results in a translational frameshift in ERa mRNA by the splicing of exon II and IV; thus, we generated a floxed ERa mouse line by targeting exon III. Homologous recombination was used to insert a floxed ERa allele into the ES cell genomic DNA. A self-excising neomycin cassette was used to select for targeting vector incorporation. The strategy is outlined in Fig. 1a . Homologous recombination was determined by Southern Blot of an EcoRV-digested ES cell genomic DNA (Fig. 1b) , using the probe consisting of a PstI/BglII fragment obtained from intron II (Probe, Fig. 1a) . Targeted ES cells were injected into C57BL/6 blastocysts. The self-excising tACE-Cre/Neo cassette was then removed from the mutant allele in vivo. Retaining a Neo cassette in vivo was shown to have unpredictable consequences on the phenotype of mice, including the generation of a hypomorphic allele with a wide range of phenotypic abnormalities [21, 22] , and mis-regulation of adjacent genes [23] . The tACE (angiotensin-converting enzyme) promoter present in the ACN cassette has been shown to specifically activate Cre recombinase activity in the testis sperm cells, but not in other tissues [17] . Thus, self-excision of the ACN cassette in the sperm of chimeric male mice resulted in transmitting the mutant allele that contained the floxed ERa gene, lacking the ACN cassette, to the F1 progeny. F1 mice heterozygous for the Type II deletion were selected (heterozygote floxed ERa mice, ERa fl/? ) via Southern blot and PCR analysis of tail DNA and bred to generate homozygous floxed ERa mice (ERa fl/fl ). (Fig. 1c, lanes 1-6 , respectively). PCR products were cloned and further sequenced to confirm that the targeted fragment contained the predicted sequence (data not shown). The disruption of ERa gene expression was also confirmed by semi-quantitative RT-PCR of messenger RNA from the uterus. Using the primer set of P3 and P4 located in exon II and IV, a PCR product of 177 bp was amplified from reverse transcribed cDNA of ACTB-cre/ERa -/-uterus. Reverse transcribed cDNA of Wt mouse uterus produced a 367 bp product, consistent with the expected size of the Wt locus, while ACTB-cre/ ERa ?/-heterozygous mice reveal the presence of a Wt (367 bp) and KO (177 bp) transcript (Fig. 1d) . DNA sequencing showed that the KO transcripts completely lack exon III (data not shown).
Results and discussions
Generation of floxed
Further confirmation of the complete null ERa mutant in the ACTB-Cre/ERa -/-mice Deletion of exon III by Cre-mediated recombination resulted in a premature stop codon at the new codon 158 position due to the splicing of exon II and IV. Thus, the putative truncated ERa protein from ACTB-Cre/ERa -/-mice would be predicted to be 157 a.a. in length in the absence of a.a. from the ERa DBD and LBD. To examine whether the putative mouse ERa N polypeptide (a.a. 1-157) is expressed in the ACTB-Cre/ERa -/-uterine extracts, we first validated which ERa antibody can recognize mouse ERa N terminus. A rabbit polyclonal antibody, H184, was originally generated to recognize the N terminus of human ERa (a.a. 2-185). Previous studies have shown that this antibody could recognize the mouse ERa [24] ; however, the immunoreactive epitopes of H184 are not well characterized. It was unclear whether H184 could recognize the first 157 a.a. of mouse ERa. Therefore, the mouse ERa N terminus (a.a. 1-157) was cloned and expressed in Cos-1 cells. The Cos-1 cell lysates were subjected to western blot analysis using the H184 antibody, and our results indicate that this antibody could detect both mouse ERa full-length and N-terminal polypeptide (a.a. 1-157) (Fig. 2a, lanes 2 and 3) .
We then used western blot analysis to examine whether ERa N terminus was expressed in ACTB-Cre/ERa -/-uterine extracts using the H184 antibody. The Wt and neoERa -/-mice revealed a 65-kD ERa protein and a novel 61-kD E1 protein, respectively (Fig. 2b, lanes 1, 2 and 5,  6 ). In contrast, the disruption of ERa in our ACTB-Cre/ ERa -/-mice resulted in the absence of the putative ERa N-terminal 157-amino-acid polypeptide (Fig. 2b, lanes 7  and 8) . The deletion of ERa exon III in the ACTB-Cre/ ERa -/-mice produces a nonsense mutation that results in a premature termination codon in ERa exon IV. The studies in the eukaryotic cells have shown that the nonsense mutation may lead to mRNA decay and prevent the accumulation of truncated protein [25] . Although it is expected that the premature termination codon in the ERa exon IV will yield a 157-amino-acid N-terminal ERa polypeptide, nonsense-mediated mRNA decay (NMD) could degrade the mutant ERa mRNAs containing the premature termination codon and prevent the synthesis of the 157-amino-acid N-terminal ERa polypeptide in the ACTB-Cre/ERa -/-mice. It is also possible that the ERa N terminus is present, but undetectable, in ACTB-Cre/ ERa -/-mice, due to instability of the protein. To our knowledge, this is the first report to definitely show the absence of the ERa N terminus in ERaKO mice.
Moreover, using the MC-20 antibody, recognizing the ERa C terminus, western blotting of Wt uterine extracts revealed not only a 65-kD product, consistent with fulllength ERa, but also a 46-kD product ERa D1. This is an isoform of ERa splicing of exon II and encodes an in-frame ERa protein with intact DBD and LBD domains by utilizing the start codon in exon III and a favorable Kozak sequence (Fig. 2c, lanes 1 and 2) [26] . The ERa D1 protein was found to be expressed in the mouse uterus and human cells [27, 28] . In the previously generated neo-ERa -/-mice, a 65-kD full-length ERa protein was not detectable, but a 61-kD-truncated E1 protein was detected in the uterine extracts of neo-ERa -/-mice, which was consistent with the results detected by ERa antibody H-184 (Fig. 2c,  lanes 5 and 6) . In addition, a 46-kD ERa D1 was detected in the uterine extracts of neo-ERa -/-mice (Fig. 2c , lanes 5 and 6). Our ACTB-Cre/ERa -/-mice did not express ERa D1 due to the deletion of exon III. Collectively, the full disruption of ERa in our ACTB-Cre/ERa -/-mice was shown by the absence of any ERa residual protein immunoreactivity with either the ERa-N-terminal antibody (H-184) or ERa-C-terminal antibody (MC-20) in the uterine extracts (Fig. 2b, c) .
In addition, we examined ERa expression in the paraffin-embedded uterine tissue by IHC staining. ERa was mainly expressed in the uterine stromal and glandular epithelial cells with little positive nuclear staining in the luminal epithelial cells of 3-month-old Wt mice (Fig. 2d, arrows) . The majority of positive ERa staining in the stromal cells was abolished in the neo-ERa -/-uterus, however, the positive nuclear ERa staining can still be found in some glandular epithelial and stromal cells (Fig. 2d, arrowheads) . In contrast, there was no positive nuclear ERa staining, which could be detected in the ACTB-Cre/ERa -/-mice, except some diffuse cytoplasmic background staining (Fig. 2d) .
Real-time PCR analysis was used to detect the transcription of estrogen target genes in the mouse uterine tissue. Compared to the Wt mice, the expressions of G-6-PD and lactoferrin in neo-ERa -/-uterus were 0.44 ± 0.125 and 0.265 ± 0.057, respectively, whereas, the expressions of G-6-PD and lactoferrin in the ACTB-Cre/ERa -/-uterus were dramatically decreased to 0.093 ± 0.051 and 0.050 ± 0.012, respectively (Fig. 2e) . Collectively, these results demonstrate that our newly generated ACTB-Cre/ERa -/-mice are indeed a complete ERa null mutant and provide a mouse model completely lacking in ERa signaling to study the role of ERa in vivo. Furthermore, direct comparisons with the neo-ERa -/-mouse underscore the value of analyzing the ACTB-Cre/ERa -/-mice as a model of ERa deficiency.
Defective reproductive system in ACTB-Cre/ERa -/-females To confirm the phenotypes that have been reported in other ERaJO mouse models, more than five age-matched littermates were used for each experiment. ACTB-Cre/ERa -/-females had similar appearing external genitalia as Wt females; however, the vagina of ACTB-Cre/ERa -/-females did not display any cyclic changes when vaginal smears were performed (data not shown). Gross internal anatomical examination revealed that ACTB-Cre/ERa -/-uterus and vagina were hypoplastic and presented a much more severe uterine phenotype than the hypomorphic phenotype (half the weight of Wt littermates) in the neo-ERa -/-uterus ( Fig. 3a) [1] . Histological analyses showed that the ACTB-Cre/ERa -/-uterus contained substantially reduced numbers of stromal cells in both the myometrium and lamina propria, which resulted in significant differences in the uterine diameter between Wt and ACTB-Cre/ERa -/-females, however, the length of uterus had no significant difference between Wt and ACTB-Cre/ERa -/-females (Fig. 3b, I vs. II; III vs. IV), which indicate that the growth of uteri along the body axis is independent of ERa function. This finding agrees with other ERaKO models [8] .
As shown in Fig. 3c , in the ovary of Wt mice, primordial follicles (PR, arrowhead), primary follicles (P), antral follicles (AF), and corpus luteum (CL) were all present and well organized, and the interstitial compartment (IT) was abundant and consisted of compact clusters of glandular and fibroblast cells. In contrast, ovaries from adult ACTBCre/ERa -/-females displayed many large dilated, hemorrhagic cysts (CY). The primordial follicles (PR, arrowhead) and primary follicles were observed in the ACTB-Cre/ERa -/-ovary, but with greatly reduced numbers compared to Wt mice. The antral follicles were also observed in ACTB-Cre/ERa -/-ovaries (AF); however, the thickness of the granulosa cells in the antral follicles of ACTB-Cre/ERa -/-females was significantly reduced (red ovaries had few interstitial compartments, but an excess of atretic follicles which were derived from the apoptotic antral follicles due to their inability to develop to the preovulatory stage (A). No corpus luteum was observed in ACTB-Cre/ERa -/-ovaries. Overall, folliculogenesis in ACTB-Cre/ERa -/-females is defective and can only progress into the antral stage. These findings agree with previous studies showing that a functional ERa is required for the functional maturation of preovulatory follicles [8, 29] . Furthermore, our results also suggest that ERa is necessary for interstitial glandular cell development.
Increased body weight and infertility of ACTB-Cre/ERa -/-females
The analyses of ACTB-Cre/ERa -/-females showed that they developed obesity: the body weight of young adult ACTB-Cre/ERa -/-females (12-week-old) was significantly higher than the control mice (P \ 0.05, Fig. 4a ). ACTB-Cre/ERa -/-females had significant lipid accumulation in the subcutaneous white adipose tissues (WATs) (data not shown). Those results agree with other studies that have examined the increased body weight of ovariectomized mice and neo-ERa -/-females, as well as the role of ERa in suppressing the development of WATs [30, 31] . In agreement with previously published results [8, 11] , ACTB-Cre/ERa -/-females were infertile as shown by 18 weeks of continuous mating test (Fig. 4b) . Fertility of Wt and ACTB-Cre/ERa ?/-females was normal and comparable.
In conclusion, we have generated floxed ERa mice using a self-excising ACN (tACE-Cre/Neo) cassette. Although both Dupont et al. [8] and Feng et al. [13] have generated floxed ERa mice, our floxed ERa mice were developed using a different targeting construct strategy (Table 1) . It is true that this mouse model would be one of three reporting a floxed ERa locus, however, ours is the only study that actually compares the effect of an in vivo deletion of exon III with the insertional mutagenesis used to produce the neoERa -/-mouse. We show a much more severe uterine phenotype when exon III is deleted in the ACTB-Cre/ ERa -/-females than the hypomorphic phenotype in neoERa -/-females [1] . Furthermore, we characterized any residual ERa protein being expressed in ERaKO mice (Table 1) . We showed in mouse uterine extracts that our ACTB-Cre/ERa -/-mice lack any detectable ERa protein versus a truncated protein in the neo-ERa -/-line using antibodies recognizing either the N-terminus or C-terminus of ERa. To our knowledge, this is the first report to definitely show the absence of the ERa N terminus in ERaKO mice. We also showed that there are almost completely abolished expressions of ERa target genes, G-6-PD and lactoferrin, in the ACTB-Cre/ERa -/-uterus, whereas expression of these genes was still 44% and 27% of Wt values, respectively, in the neo-ERa -/-uterus. Using our ACTB-Cre/ERa -/-mouse model, we have characterized the function of ERa in the female genital tracts. These studies form the basis for the use of the floxed ERa mouse to selectively and completely delete the ERa gene in a tissue-or temporal-specific manner by breeding with transgenic mice harboring promoter specific Cre. The complete knockout of ERa in the ACTB-Cre/ ERa -/-mice also provides an improved mouse model to study the role of ERa in vivo. 
